Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS

Source: CCO Independent Conference Coverage: Clinical Impact of New HIV Data From Fall 2022 Conferences*

Washington, DC - October 19-23, 2022; Glasgow, Scotland and virtual - October 23-26, 2022

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at IDWeek and HIV Glasgow 2022, including prevention strategies, long-acting therapies, and investigational agents.

Chloe Orkin, MBChB, FRCP, MD

Babafemi Taiwo, MBBS

Released: November 30, 2022

Information on this Educational Activity

Faculty

Chloe Orkin, MBChB, FRCP, MD

Professor of HIV
Queen Mary, University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead Sciences, Janssen, MSD, ViiV Healthcare; researcher: AstraZeneca, Gilead Sciences, Janssen, MSD, ViiV Healthcare.

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS: consultant/advisor/speaker: Gilead Sciences, Johnson & Johnson, ViiV Healthcare.

Program Medium

This program has been made available online.

Welcome to the CCO Site

Key HIV Studies Influencing My Practice Following IDWeek and HIV Glasgow 2022—Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS

Information on this Educational Activity

Faculty

Program Medium

Leaving the CCO site